A prior investigation demonstrated that the diagnostic sensitivity of SHOX2 and RASSF1A combined methylation in lung adenocarcinoma was 52.5%, whereas cytology exhibited a sensitivity of 13.3%. Here, SHOX2 is linked to lung adenocarcinoma.